Opening book details…
About this Medicine article
Is the "3+3" Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design by Rahma, O. E.; Gammoh, E.; Simon, R. M.; Khleif, S. N. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Rahma, O. E.; Gammoh, E.; Simon, R. M.; Khleif, S. N.
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Rahma, O. E.; Gammoh, E.; Simon, R. M.; Khleif, S. N.
Browse all works by Rahma, O. E.; Gammoh, E.; Simon, R. M.; Khleif, S. N.